Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

67 insider filings · Latest: Aug 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 5, 2026Mar 5 10:43 PMJover Placid
Proposed Sale
14,150$31.67$448.1K

View →

Mar 5, 2026Mar 5 10:39 PMSavage Brian
Proposed Sale
1,127$31.67$35.7K

View →

Mar 5, 2026Mar 5 10:32 PMFox Christine
Proposed Sale
7,924$31.67$250.9K

View →

Mar 5, 2026Mar 5 10:26 PMFrancis Richard D
Proposed Sale
20,025$31.67$634.2K

View →

Mar 5, 2026Mar 5 10:13 PMHughes Eric A
Proposed Sale
9,533$31.67$301.9K

View →

Mar 5, 2026Mar 5 10:08 PMDaniell Richard
Proposed Sale
17,295$31.67$547.7K

View →

Mar 3, 2026Mar 5 9:09 PMRichard DaniellEVP, Europe Commercial
Sale
128,985$32.36$4.2M123,127(D)

View →

Mar 3, 2026Mar 5 9:06 PMBrian SavageInterim Chief Legal Officer
Sale
1,274$32.36$41.2K2,926(D)

View →

Mar 3, 2026Mar 5 9:05 PMRichard D FrancisPresident and CEO
Sale
442,935$32.36$14.3M1,121,382(D)

View →

Mar 3, 2026Mar 5 9:01 PMEric A HughesSee "Remarks"
Sale
80,762$32.36$2.6M85,616(D)

View →

Mar 4, 2026Mar 4 10:42 PMFox Christine
Proposed Sale
9,908$32.46$321.7K

View →

Mar 4, 2026Mar 4 10:36 PMFrancis Richard D
Proposed Sale
23,393$32.46$759.4K

View →

Mar 4, 2026Mar 4 10:28 PMHughes Eric A
Proposed Sale
11,277$32.46$366.1K

View →

Mar 4, 2026Mar 4 10:22 PMDaniell Richard
Proposed Sale
91,345$32.66$3.0M

View →

Mar 3, 2026Mar 3 10:46 PMSavage Brian
Proposed Sale
1,274$32.36$41.2K

View →

Mar 3, 2026Mar 3 10:34 PMFrancis Richard D
Proposed Sale
442,935$32.36$14.3M

View →

Mar 3, 2026Mar 3 10:25 PMHughes Eric A
Proposed Sale
80,762$32.36$2.6M

View →

Mar 3, 2026Mar 3 10:13 PMDaniell Richard
Proposed Sale
128,985$32.36$4.2M

View →

Feb 26, 2026Mar 2 9:01 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Sale
345,810$33.64$11.6M57,478(D)

View →

Feb 26, 2026Feb 26 9:11 PMKalif Eliyahu Sharon
Proposed Sale
345,810$33.64$11.6M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 6 9:13 PMMark SabagSee "Remarks"
Option Exercise
52,11337,202(D)

View →

Mar 4, 2026Mar 6 9:11 PMEvan LippmanEVP, Business Development
Grant/Award
27,34727,347(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Option Exercise
23,25146,503(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Grant/Award
50,64350,643(D)

View →

Mar 4, 2026Mar 6 9:08 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
56,76346,503(D)

View →

Mar 4, 2026Mar 6 9:08 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Grant/Award
53,17553,175(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Option Exercise
20,46140,923(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Grant/Award
50,64350,643(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Option Exercise
8,5107,534(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Grant/Award
11,28011,280(D)

View →

Mar 4, 2026Mar 6 9:01 PMAmir WeissChief Accounting Officer
Grant/Award
11,28011,280(D)

View →

Mar 4, 2026Mar 6 9:01 PMAmir WeissChief Accounting Officer
Option Exercise
16,32911,300(D)

View →

Mar 3, 2026Mar 5 9:11 PMAmir WeissChief Accounting Officer
Option Exercise
5,1795,180(D)

View →

Mar 3, 2026Mar 5 9:09 PMRichard DaniellEVP, Europe Commercial
Option Exercise
203,7280(D)

View →

Mar 3, 2026Mar 5 9:08 PMMark SabagSee "Remarks"
Option Exercise
166,3780(D)

View →

Mar 3, 2026Mar 5 9:06 PMBrian SavageInterim Chief Legal Officer
Option Exercise
3,4613,461(D)

View →

Mar 3, 2026Mar 5 9:05 PMRichard D FrancisPresident and CEO
Option Exercise
958,5460(D)

View →

Mar 3, 2026Mar 5 9:03 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
191,2780(D)

View →

Mar 3, 2026Mar 5 9:01 PMEric A HughesSee "Remarks"
Option Exercise
166,3780(D)

View →

Feb 15, 2026Feb 18 9:01 PMRichard D FrancisPresident and CEO
Option Exercise
781,7660(D)

View →